Of clinical importance, in breast cancer that may be or is hormone-receptor negative, like invasive ductal and basal-like cancer, transcriptional regulation of the NDRG2 gene seems to be irrespective of hormone expression thus the putative tumor suppressive function of NDRG2 may be confined to luminal-type breast cancers. Here, NR4A1 is linked to breast cancer.